These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7398247)

  • 21. Reduction in tardive dyskinesia symptoms during treatment with olanzapine or haloperidol.
    Kinon BJ; Kollack-Walker S; Stauffer V; Liu-Seifert H
    J Clin Psychopharmacol; 2012 Jun; 32(3):420-2. PubMed ID: 22561475
    [No Abstract]   [Full Text] [Related]  

  • 22. Predictors of acute dystonia in first-episode psychotic patients.
    Aguilar EJ; Keshavan MS; Martínez-Quiles MD; Hernández J; Gómez-Beneyto M; Schooler NR
    Am J Psychiatry; 1994 Dec; 151(12):1819-21. PubMed ID: 7977894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acutely disturbed psychotic patients treated with parenteral haloperidol.
    Firling RJ
    IMJ Ill Med J; 1978 Feb; 153(2):117. PubMed ID: 24024
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparative effectiveness of antipsychotic drugs.
    Meibach RC
    Am J Psychiatry; 2003 Mar; 160(3):589-90; author reply 592-3. PubMed ID: 12611851
    [No Abstract]   [Full Text] [Related]  

  • 25. Haloperidol in psychiatry.
    Med Lett Drugs Ther; 1975 Jan; 17(3):11-2. PubMed ID: 1092991
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effective management of the acute psychotic patient: stabilization and maintenance with haloperidol].
    Garfinkel PE
    Acta Psiquiatr Psicol Am Lat; 1978 Dec; 24(4):297-301. PubMed ID: 36735
    [No Abstract]   [Full Text] [Related]  

  • 27. Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder.
    Kane JM; Carson WH; Saha AR; McQuade RD; Ingenito GG; Zimbroff DL; Ali MW
    J Clin Psychiatry; 2002 Sep; 63(9):763-71. PubMed ID: 12363115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double-blind comparison of risperidone and haloperidol in schizophrenic and schizoaffective psychoses.
    Cesková E; Svestka J
    Pharmacopsychiatry; 1993 Jul; 26(4):121-4. PubMed ID: 7694306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical experience with bromperidol in chronic psychoses].
    Bellomo LE; Rosset N; Tellarini L; Forconesi N
    Acta Psiquiatr Psicol Am Lat; 1988 Sep; 34(3):230-6. PubMed ID: 3071092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of clozapine, olanzapine, risperidone, and haloperidol in schizophrenia and schizoaffective disorder assessed with nurses observation scale for inpatient evaluation.
    Volavka J; Nolan KA; Kline L; Czobor P; Citrome L; Sheitman B; Lindenmayer JP; McEvoy J; Lieberman JA
    Schizophr Res; 2005 Jul; 76(1):127-9. PubMed ID: 15927808
    [No Abstract]   [Full Text] [Related]  

  • 31. Determining the optimal dose of haloperidol in first-episode psychosis.
    Oosthuizen P; Emsley RA; Turner J; Keyter N
    J Psychopharmacol; 2001 Dec; 15(4):251-5. PubMed ID: 11769818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative efficacy of red cell and plasma haloperidol as predictors of clinical response in schizophrenia.
    Smith RC; Baumgartner R; Shvartsburd A; Ravichandran GK; Vroulis G; Mauldin M
    Psychopharmacology (Berl); 1985; 85(4):449-55. PubMed ID: 2862652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safe use of haloperidol in a patient with cardiac dysrhythmia.
    Cameron OG
    Am J Psychiatry; 1978 Oct; 135(10):1244. PubMed ID: 696913
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy and side effects of haloperidol in psychotic patients: oral versus intravenous administration.
    Möller HJ; Kissling W; Lang C; Doerr P; Pirke KM; von Zerssen D
    Am J Psychiatry; 1982 Dec; 139(12):1571-5. PubMed ID: 7149056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Open clinical trial with haloperidol decanoate in patients with psychotic disorders].
    Ellerman LA
    Acta Psiquiatr Psicol Am Lat; 1987 Jun; 33(2):157-62. PubMed ID: 3321918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial.
    Schooler N; Rabinowitz J; Davidson M; Emsley R; Harvey PD; Kopala L; McGorry PD; Van Hove I; Eerdekens M; Swyzen W; De Smedt G;
    Am J Psychiatry; 2005 May; 162(5):947-53. PubMed ID: 15863797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Questions about rapid treatment.
    Carpenter WT
    Am J Psychiatry; 1977 May; 134(5):584-5. PubMed ID: 848596
    [No Abstract]   [Full Text] [Related]  

  • 38. Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol.
    Andrezina R; Josiassen RC; Marcus RN; Oren DA; Manos G; Stock E; Carson WH; Iwamoto T
    Psychopharmacology (Berl); 2006 Oct; 188(3):281-92. PubMed ID: 16953381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [30 years experience with haloperidol].
    Bandelow B; Müller P; Rüther E
    Fortschr Neurol Psychiatr; 1991 Aug; 59(8):297-321. PubMed ID: 1937339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RBC and plasma levels of haloperidol and clinical response in schizophrenia.
    Smith RC; Vroulis G; Shvartsburd A; Allen R; Lewis N; Schoolar JC; Chojnacki M; Johnson R
    Am J Psychiatry; 1982 Aug; 139(8):1054-6. PubMed ID: 7091432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.